Xopenex

Asthma and chronic bronchitis are two of the life-threatening respiratory diseases that have plagued more than a million people worldwide. Asthma is a chronic bronchial disease characterized by inflammation and constricting of the airways caused by allergens and environmental factors. This disease is mostly prevalent in children who dwell in urban areas. On the other hand, chronic bronchitis is mostly caused by tobacco smoking and dust and fibers such as asbestos. It is marked by a limitation in the bronchi and bronchioles because of the build-up of matters and unusual sputum production. This disease is common in adults, in particular the chronic tobacco smokers and workers exposed to fibers. Asthma and chronic bronchitis can be diagnosed by a bronchodilator, habit change and change of environment.

Bronchodilator is the convenient treatment for asthma and chronic bronchitis. Bronchodilator, which can be obtained in its brand Xopenex, is medicated to relax the muscles in the bronchi. This action forces the airway to widen, permitting air to be inhaled and exhaled with ease.

Xopenex Versus Albuterol

Xopenex generic name is levalbuterol, an R-enantiomer of the drug albuterol. Levalbuterol is an alternative to the drug albuterol, although both have the same properties. Sempracor, the manufacturer of levalbuterol, has formulated the similar abulterol properties. However, levalbuterol has only R-isomer that provides the therapeutic effects while albuterol has R-isomer and S-isomer. S-isomer is an unnecessary content of albuterol. This is with an implication that the mere formulation would only exhibit fewer adverse effects. It is claimed, likewise, that the drug would produce less effect to the heart than albuterol when it is prescribed to patients with arrythmias. It is also a good substitute to hyperactive-inducing albuterol when prescribed to children. These claims have yet to be clinically studied. The weighing of the therapeutic effects and side effects of levalbuterol and albuterol is still at large.

Xopenex is formulated in metered-dose inhaler and nebulizer. Xopenex inhaler has a propellant that does not contain ozone-destructive chlorofluorocarbon. Hydrofluoroalkane, an environment-friendly alternative is used. The inhaler can be conveniently medicated anywhere and can be used up to 200 sprays. Before emptying the inhaler, it would be better to consult the prescribing doctor for a decision for another refill. Correct technique for using the item is demonstrated by the physician.

Xopenex nebulizer is used when older and young patients cannot coordinate with an inhaler for treating asthma. The nebulizer comes with a tube and a facemask, for easy breathing of the mist containing the medication. The mist is produced by the mechanism of the nebulizer from the drug’s liquid form. Demonstration on the procedure and technique for effectively medicating Xopenex nebulizer is conducted by the physician.

Medication of the nebulizer takes several minutes and may take up the time of an assistant during the procedural treatment.

Anticipation for side effects from a drug like Xopenex is very unlikely. It would be good to inquire the physician of the possible undesirable effects of the drug. If side effects occur in conjunction with the medication and the symptoms may have become bothersome, prompt medical assistance would be necessary.

Side effects that may commonly occur during the prescription of Xopenex include flu symptoms, runny nose, tremors, nervousness and cough. Diarrhea, headache, hives, muscle pain, sore throat, weakness, viral infections and fever are symptoms from the drug that may occur in children.

Allergies may become severe if drug is medicated, particularly when allergic reactions to the drug have not been encountered before. If this sign occurs, contact the prescribing physician for initial remedy. The doctor may decide on the best alternative.

More information of the drug can be obtained in a medical literature online or through a consultation with the physician. Inquiries on the availability of the drug can also be made during the consultation.